NO20081043L - Vaksine for fisk - Google Patents
Vaksine for fiskInfo
- Publication number
- NO20081043L NO20081043L NO20081043A NO20081043A NO20081043L NO 20081043 L NO20081043 L NO 20081043L NO 20081043 A NO20081043 A NO 20081043A NO 20081043 A NO20081043 A NO 20081043A NO 20081043 L NO20081043 L NO 20081043L
- Authority
- NO
- Norway
- Prior art keywords
- polypeptide
- protein
- relates
- carrier
- nucleic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/18—Togaviridae; Flaviviridae
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
- C12N2770/36122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
- C12N2770/36134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Foreliggende oppfinnelse angår veterinær immunologi, det vil si den immunologiske responsen hos fisk på et virus. Nærmere bestemt tilveiebringer oppfinnelsen en epitop av salmonid alfavirus hvilken epitop er i stand til å indusere en virusnøytraliserende immunrespons. Spesielt angår oppfinnelsen et polypeptid omfattende en bestemt aminosyresekvens, et protein omfattende slikt polypeptid, en bærer omfattende slikt protein og en fremgangsmåte for fremstilling av antistoffer. Videre angår oppfinnelsen en nukleinsyre som koder for slikt polypeptid eller slikt protein og en bærer omfattende en slik nukleinsyre. Oppfinnelsen angår også en vaksine og et diagnostisk sett omfattende et slikt polypeptid, protein, bærer eller nukleinsyre.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05020223 | 2005-09-16 | ||
PCT/EP2006/066401 WO2007031572A1 (en) | 2005-09-16 | 2006-09-15 | Fish vaccine |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20081043L true NO20081043L (no) | 2008-04-07 |
NO341881B1 NO341881B1 (no) | 2018-02-12 |
Family
ID=35064703
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20081043A NO341881B1 (no) | 2005-09-16 | 2008-02-28 | Polypeptid, protein, metode for fremstilling av salmonid alphavirus nøytraliserende antistoffer, nukleinsyre, bærer, vaksine og diagnostisk sett |
Country Status (7)
Country | Link |
---|---|
US (2) | US7794724B2 (no) |
EP (1) | EP1928898B1 (no) |
JP (1) | JP5300479B2 (no) |
CA (1) | CA2622610C (no) |
DK (1) | DK179025B1 (no) |
NO (1) | NO341881B1 (no) |
WO (1) | WO2007031572A1 (no) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK179025B1 (da) * | 2005-09-16 | 2017-08-28 | Intervet Int Bv | Fiskevaccine |
TW200936759A (en) * | 2007-12-21 | 2009-09-01 | Intervet Int Bv | Fish vaccine |
NO333242B1 (no) * | 2008-02-08 | 2013-04-15 | Pharmaq As | Sammensetning, medisinsk anvendelse og fremgangsmate som omfatter salmonid alfavirus |
NO346489B1 (no) * | 2008-02-08 | 2022-09-05 | Pharmaq As | Anvendelse av inaktivert SAV i fremstilling av en vaksine. |
CA2776534A1 (en) * | 2009-10-02 | 2011-04-07 | The Trustees Of Columbia University In The City Of New York | Piscine reovirus diagnostic compositions |
ES2588225T3 (es) | 2010-04-21 | 2016-10-31 | Pharmaq As | Secuencias de ácido nucleico de un virus de pece y el uso de las mismas |
US9139618B2 (en) * | 2010-12-29 | 2015-09-22 | Intervet Inc. | Salmonid alphavirus protein E2 |
EP2688587B2 (en) | 2011-03-25 | 2023-08-16 | Intervet International B.V. | Salmonid alphavirus vaccine |
GB201204280D0 (en) * | 2012-03-09 | 2012-04-25 | Univ Nordland | Methods |
DK178233B1 (en) * | 2012-09-17 | 2015-09-14 | Novartis Tiergesundheit Ag | Fiskevaccine |
WO2014118385A1 (en) | 2013-02-04 | 2014-08-07 | University of Tromsø | The use of dna sequences encoding an interferon as vaccine adjuvants |
GB2551984B (en) | 2016-06-30 | 2019-01-16 | Pharmaq As | Fish virus |
NO20200827A1 (en) * | 2017-12-26 | 2020-07-14 | Univ Chile | Vaccine formulation for fish based on lipid nanovesicles,particularly a proteoliposome or cochleate, with activity against the salmonid rickettsial syndrome (srs) |
CA3123504A1 (en) * | 2018-12-21 | 2020-06-25 | Intervet International B.V. | Serum free intracellular pathogen vaccine |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0382271B1 (en) | 1989-02-04 | 1994-12-21 | Akzo Nobel N.V. | Tocols as adjuvant in vaccine |
AUPM873294A0 (en) | 1994-10-12 | 1994-11-03 | Csl Limited | Saponin preparations and use thereof in iscoms |
PT712926E (pt) | 1994-10-18 | 2004-02-27 | Akzo Nobel Nv | Virus da doenca pancreatica do peixe |
US6719980B1 (en) * | 1998-05-08 | 2004-04-13 | Akzo Nobel Nv | Structural proteins of fish pancreatic disease virus and uses thereof |
DK1140152T3 (da) | 1998-12-21 | 2003-12-01 | Akzo Nobel Nv | Fremgangsmåde til fremstilling af inaktiverede v/o-emulsion-adjuvans-vacciner |
FR2839453B1 (fr) | 2002-05-07 | 2007-05-11 | Agronomique Inst Nat Rech | Utilisation de novirhabdovirus modifies pour l'obtention de vaccins |
DK179025B1 (da) * | 2005-09-16 | 2017-08-28 | Intervet Int Bv | Fiskevaccine |
-
2006
- 2006-09-14 DK DKPA200601181A patent/DK179025B1/da active
- 2006-09-15 EP EP06793552.8A patent/EP1928898B1/en active Active
- 2006-09-15 CA CA2622610A patent/CA2622610C/en active Active
- 2006-09-15 JP JP2008530541A patent/JP5300479B2/ja active Active
- 2006-09-15 WO PCT/EP2006/066401 patent/WO2007031572A1/en active Application Filing
- 2006-09-15 US US12/066,868 patent/US7794724B2/en active Active
-
2008
- 2008-02-28 NO NO20081043A patent/NO341881B1/no unknown
-
2010
- 2010-08-16 US US12/857,015 patent/US8435536B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
CA2622610A1 (en) | 2007-03-22 |
WO2007031572A1 (en) | 2007-03-22 |
US20110135659A1 (en) | 2011-06-09 |
NO341881B1 (no) | 2018-02-12 |
DK179025B1 (da) | 2017-08-28 |
DK200601181A (da) | 2007-03-17 |
US7794724B2 (en) | 2010-09-14 |
CA2622610C (en) | 2017-02-21 |
JP2009507509A (ja) | 2009-02-26 |
EP1928898B1 (en) | 2014-08-20 |
EP1928898A1 (en) | 2008-06-11 |
US8435536B2 (en) | 2013-05-07 |
JP5300479B2 (ja) | 2013-09-25 |
US20090162388A1 (en) | 2009-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20081043L (no) | Vaksine for fisk | |
WO2002080851A3 (en) | Chimeric vaccines | |
NO20063478L (no) | Noytraliserende epitopebasert vekstfremmende vaksine | |
NO20062044L (no) | Piscirickettsia salmonis-antigener og anvendelse derav | |
HUP0402048A2 (hu) | Eljárás specifikus patogének antigénjeinek azonosítására, izolálására és előállítására | |
NO20091665L (no) | Tumorassosierte antigenderivater fra MAGE-familien, og nuklinsyresekvenser som koder for disse, anvendt for fremstilling av fusjonsproteiner og for vaksinesammensetninger | |
IL189313A (en) | Virus-like particles as virus-paramixo vaccines, a method for their preparation and use | |
EA200701305A1 (ru) | Иммуногенные композиции, содержащие циклические пептиды, полученные из бета-амилоидного пептида | |
NO20071609L (no) | Immunogen sammensetning for anvendelse ved vaksinering mot stafylokokker | |
ATE348633T1 (de) | Verfahren zur verstärkung einer immunantwort von nukleinsäureimpfungen | |
BRPI0519705A2 (pt) | composiÇÕes, proteÍnas de fusço e mÉtodos de estimular uma resposta imune em um indivÍduo | |
ATE470673T1 (de) | Impfstoffe mit lawsoniaintrazellularis- untereinheit | |
MX2009006470A (es) | Proteina linfopoyetina estromatica timica de canino, y usos de la misma. | |
WO2000073430A3 (de) | Vakzine gegen konformationsabhängige antigene sowie gegen antigene, die keine oder nicht ausschliesslich proteine oder peptide sind | |
WO2007098718A8 (es) | Antígenos vacunales quiméricos contra el virus de la influenza aviar | |
WO2004026265A3 (en) | Compositions and methods for treatment of herpesvirus infections | |
WO2005081716A3 (en) | DNA VACCINES TARGETING ANTIGENS OF THE SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS (SARS-CoV) | |
EP4226938A3 (en) | Coronavirus vaccine | |
RU2015106916A (ru) | Полипептиды clostridium difficile в виде вакцины | |
MX2009007572A (es) | Proteinas de fusion que contienen los antigenos de rechazo de tumor ny-eso-1 y. | |
Kumar et al. | Outer membrane protein assembly factor YaeT (omp85) and GroEL proteins of Edwardsiella tarda are immunogenic antigens for Labeo rohita (Hamilton) | |
WO2023147092A3 (en) | Coronavirus vaccine | |
WO2009074861A3 (en) | Improved vaccine | |
Walczak et al. | Method for generation of peptide‐specific igy antibodies directed to Staphylococcus aureus extracellular fibrinogen binding protein epitope | |
GB2429711A (en) | Heart and skeletal muscle inflammation (HSMI) virus |